1. Funding Update: 2013 – 2015 September 10, 2013 1

2. 2 China 2013

3. 3 OVERVIEW MR Initiative Annual Expenditure 2001-2013 MR Initiative Annual Donations 2001-2013; Financial Resource Requirements through 2015 MR Initiative Financial Resource Requirements - detail MR Initiative donors, 2001 - 2013 measles & rubella moving ahead Challenges to implementation for MR Initiative

4. * Excluding country contributions MR Initiative Annual Expenditure, 2001-2013 Total expenditure 2001-2013 = $1,008 million 4

5. 11 59 363844 94 Measles & Rubella Initiative Annual Donations 2001-2015 and Financial Resource Requirements, Projections, Funding Gap 2013-2015* * Excludes all country contributions and direct social mobilization funding from partners 5

6. Measles & Rubella Initiative Financial Resource Requirements, Projections, Funding Gap 2013-2015 Anticipated Country Contributions Donor Funds Projected/Pledged/Received 32 31 18 47 Anticipated GAVI Contribution (Rubella) Funding Gap (includes PSC) Total Funding Gap 2014-2015: US $65 million 6

7. Resource Requirements by Major Category of Activity, 2014-2015 Total Cost 2014-2015: US $557 million 7

8. MR Initiative Donors, 2001-2013 * Includes ARC/UNF and other partners 8

9. Where is the Measles & Rubella Initiative Headed? Toward regional achievement of Measles Rubella Elimination Goals by or before 2020 Improvement of routine coverage and timely and high quality SIAs Expanded use of accurate data for decision making 2012 measles goals: AFRO (pre-elimination) and WPRO (elimination) - missed 2013 potential SEARO elimination goal set (waiting), begin MR introduction campaigns with GAVI support (done) 2015 GIVS (95% mortality reduction) and MDG 4 goals; measles goal in EMRO and EURO (elimination); rubella goal in EURO (elimination); continue to set regional rubella elimination goals as appropriate 2020 Measles goal in AFRO (elimination) Critical Elements for Success Political leadership Timely funding (donor and national governments) Adequate time for planning and social mobilization (9 months) Well performing surveillance, analysis & use of data to improve coverage 9

10. Challenges to Implementation for MR Initiative Lack of timely and sufficient funding: few multiyear grants Ensuring high quality SIA’s (increased training and social mobilization cost, increased technical assistance request) Providing strategic support for non-GAVI eligible countries (TA, Surveillance) Increased surveillance cost (including lab, coverage surveys) Projecting target age range for SIA’s several years in advance Projecting cost to MR Initiative for target populations above 59 months for GAVI funded measles SIA’s in 6 large countries Routine immunization: scale up of MCV1, increased MCV2 introduction and coverage, other routine strengthening immunization activities 10

11. Anne Ray Charitable Trust 11